isoflurophate has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ATHENS, JW | 1 |
RAAB, SO | 1 |
HAAB, OP | 1 |
BOGGS, DR | 1 |
ASHENBRUCKER, H | 1 |
CARTWRIGHT, GE | 1 |
WINTROBE, MM | 1 |
1 other study available for isoflurophate and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
LEUKOKINETIC STUDIES. X. BLOOD GRANULOCYTE KINETICS IN CHRONIC MYELOCYTIC LEUKEMIA.
Topics: Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Cell Division; Colchicine; Granulocytes; H | 1965 |